×
Predicting Remission From Depression in Youth Receiving Outpatient Medication Management PDF
$ 40.00
Predicting Remission From Depression in Youth Receiving Outpatient Medication Management PDF quantity
$ 40.00
×
Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder PDF
$ 40.00
Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder PDF quantity
$ 40.00
×
A Review of the Midlevel Care Provider System in New York State PDF
$ 40.00
A Review of the Midlevel Care Provider System in New York State PDF quantity
$ 40.00
×
Effects of Adjunctive Brexpiprazole on Sleep Disturbances in Patients With Major Depressive Disorder: An Open-Label, Flexible-Dose, Exploratory Study PDF
$ 40.00
Effects of Adjunctive Brexpiprazole on Sleep Disturbances in Patients With Major Depressive Disorder: An Open-Label, Flexible-Dose, Exploratory Study PDF quantity
$ 40.00
×
Association Between White Matter Hyperintensity Severity and Cognitive Impairment According to the Presence of the Apolipoprotein E (APOE ) ε4 Allele in the Elderly: Retrospective Analysis of Data From the CREDOS Study PDF
$ 40.00
Association Between White Matter Hyperintensity Severity and Cognitive Impairment According to the Presence of the Apolipoprotein E (APOE) ε4 Allele in the Elderly: Retrospective Analysis of Data From the CREDOS Study PDF quantity
$ 40.00
×
Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study PDF
$ 40.00
Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study PDF quantity
$ 40.00
×
Withdrawal From Controlled Carbamazepine Therapy Followed by Further Carbamazepine Treatment in Patients With Dementia PDF
$ 40.00
Withdrawal From Controlled Carbamazepine Therapy Followed by Further Carbamazepine Treatment in Patients With Dementia PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart